Literature DB >> 14618083

The 113th and 117th charged amino acids in the 5th alpha-helix of the HBV core protein are necessary for pgRNA encapsidation.

Soo Min Lee1, Sung Gyoo Park, Esther Park, Jae Yeon Lee, Guhung Jung.   

Abstract

Although the structure-function of hepatitis B virus (HBV) core protein has been investigated by numerous HBV core mutants, functions of many regions in the core protein are still remained to be identified. In this report, it was found that point mutations in the 113th and 117th negative-charged amino acids in the 5th helix region of the HBV core strongly affect pregenomic RNA (pgRNA) encapsidation. These mutations were introduced by site-directed mutagenesis. The following results were obtained from analyses of the mutants. First, endogenous polymerase activity (EPA) was assayed and activity was not detected only in the two mutants, E113K and E117K. Second, the pgRNA encapsidation level of each mutant related to a change in charge of two amino acid sites was evaluated. Mutations in the 113th and 117th amino acids into uncharged amino acids reduced pgRNA encapsidation levels. Moreover, changes of the two amino acids into positive-charged amino acids almost completely reduced pgRNA encapsidation levels. To test whether the mutant core proteins assembled into normal capsid particles, the assembly of the mutant core proteins was seen. However, none of the changes in the 113th and 117th amino acids affected capsid formation. From this data, it can be inferred that the above two amino acids in the 5th alpha-helix in the HBV core protein are important for pgRNA encapsidation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14618083     DOI: 10.1023/a:1026339731001

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  32 in total

1.  Core protein phosphorylation modulates pregenomic RNA encapsidation to different extents in human and duck hepatitis B viruses.

Authors:  E V Gazina; J E Fielding; B Lin; D A Anderson
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

2.  Polymerase gene products of hepatitis B viruses are required for genomic RNA packaging as wel as for reverse transcription.

Authors:  R C Hirsch; J E Lavine; L J Chang; H E Varmus; D Ganem
Journal:  Nature       Date:  1990-04-05       Impact factor: 49.962

Review 3.  Hepatitis B virus morphogenesis.

Authors:  M Nassal
Journal:  Curr Top Microbiol Immunol       Date:  1996       Impact factor: 4.291

Review 4.  The molecular biology of the hepatitis B viruses.

Authors:  D Ganem; H E Varmus
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

5.  The P gene product of hepatitis B virus is required as a structural component for genomic RNA encapsidation.

Authors:  R Bartenschlager; M Junker-Niepmann; H Schaller
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

6.  Determination of the fold of the core protein of hepatitis B virus by electron cryomicroscopy.

Authors:  B Böttcher; S A Wynne; R A Crowther
Journal:  Nature       Date:  1997-03-06       Impact factor: 49.962

7.  Cis-preferential recruitment of duck hepatitis B virus core protein to the RNA/polymerase preassembly complex.

Authors:  Fritz von Weizsäcker; Josef Köck; Stefan Wieland; Jürgen Beck; Michael Nassal; Hubert E Blum
Journal:  Hepatology       Date:  2002-01       Impact factor: 17.425

8.  The arginine-rich domain of the hepatitis B virus core protein is required for pregenome encapsidation and productive viral positive-strand DNA synthesis but not for virus assembly.

Authors:  M Nassal
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

9.  A short cis-acting sequence is required for hepatitis B virus pregenome encapsidation and sufficient for packaging of foreign RNA.

Authors:  M Junker-Niepmann; R Bartenschlager; H Schaller
Journal:  EMBO J       Date:  1990-10       Impact factor: 11.598

10.  Functional characterization of naturally occurring variants of human hepatitis B virus containing the core internal deletion mutation.

Authors:  T T Yuan; M H Lin; S M Qiu; C Shih
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

View more
  4 in total

1.  Testing the balanced electrostatic interaction hypothesis of hepatitis B virus DNA synthesis by using an in vivo charge rebalance approach.

Authors:  Pong Kian Chua; Fan-Mei Tang; Jyuan-Yuan Huang; Ching-Shu Suen; Chiaho Shih
Journal:  J Virol       Date:  2009-12-16       Impact factor: 5.103

2.  Sulfamoylbenzamide derivatives inhibit the assembly of hepatitis B virus nucleocapsids.

Authors:  Matthew R Campagna; Fei Liu; Richeng Mao; Courtney Mills; Dawei Cai; Fang Guo; Xuesen Zhao; Hong Ye; Andrea Cuconati; Haitao Guo; Jinhong Chang; Xiaodong Xu; Timothy M Block; Ju-Tao Guo
Journal:  J Virol       Date:  2013-04-10       Impact factor: 5.103

3.  A SELEX-screened aptamer of human hepatitis B virus RNA encapsidation signal suppresses viral replication.

Authors:  Hui Feng; Jürgen Beck; Michael Nassal; Kang-Hong Hu
Journal:  PLoS One       Date:  2011-11-18       Impact factor: 3.240

4.  The recombined cccDNA produced using minicircle technology mimicked HBV genome in structure and function closely.

Authors:  Xiaoyan Guo; Ping Chen; Xiaohu Hou; Wenjuan Xu; Dan Wang; Tian-Yan Wang; Liping Zhang; Gang Zheng; Zhi-Liang Gao; Cheng-Yi He; Boping Zhou; Zhi-Ying Chen
Journal:  Sci Rep       Date:  2016-05-13       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.